Federica Bovo, Donatella Lombardo, Tiziana Lazzarotto, Simone Ambretti, & Paolo Gaibani. (2022). Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against <i>KPC</i>-Producing <i>K. pneumoniae</i> Collected from Bacteremic Patients, 2018 to 2020. MDPI AG.
Chicago Style (17th ed.) CitationFederica Bovo, Donatella Lombardo, Tiziana Lazzarotto, Simone Ambretti, and Paolo Gaibani. Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam Against <i>KPC</i>-Producing <i>K. Pneumoniae</i> Collected from Bacteremic Patients, 2018 to 2020. MDPI AG, 2022.
MLA (9th ed.) CitationFederica Bovo, et al. Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam Against <i>KPC</i>-Producing <i>K. Pneumoniae</i> Collected from Bacteremic Patients, 2018 to 2020. MDPI AG, 2022.